|

mFOLFOX-6 Clinical Trials

3 actively recruiting trials across 1 location

Also known as: Leucovorin, 5-fluorouracil, Oxaliplatin

Pipeline

Phase 2: 1Phase 1/2: 1Phase 2/3: 1

Top Sponsors

  • Parabilis Medicines, Inc.1
  • Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
  • Chungnam National University Hospital1

Indications

  • Cancer3
  • CTNNB11
  • APC1
  • Beta-catenin1
  • β-catenin1

Other2 trials

Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer
Phase 2/3
Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery
Phase 2

Scottsdale, Arizona1 trial

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Honor Health

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.